Evaluating potentially aberrant outpatient prescriptions for extended-release oxycodone

In early 2001, a number of media reports began to appear on the abuse and diversion of extended-release (ER) oxycodone in the United States.[1][1]–[3][2] In addition, Drug Abuse Warning Network reports noted a 108% increase in the number of possible oxycodone-associated emergency department visits